Home / Intelligence / Blog / Can GenAI be Used to Improve Data Operations Efficiency?
Published September 12, 2024
The short answer is yes, by powering process automation with GenAI. It’s an approach that hasn’t received as much attention as other GenAI use cases within life sciences, but the results can be very powerful.
To illustrate its power, we’ll examine a case study on identifying debarred healthcare professionals (HCPs).
Why is it important to identify debarred HCPs?
Pharmaceutical companies are mandated to cease all forms of engagement with debarred healthcare professionals (HCPs) in the U.S.
Compliance entails identifying and flagging HCPs from lists periodically released by government agencies, including the Food and Drug Administration (FDA), System for Award Management (SAM) and Office of Inspector General (OIG). These agencies also issue exclusion notices that call out HCPs who might be confused with debarred HCPs due to similar names and/or other identifying information.
Why is identifying debarred HCPs a challenge?
Traditional methods are only able to provide exact matches or complex potential matches, so many companies take a cautious approach and flag all the HCPs that closely match the debarred HCPs.
The core challenge with this approach is the loss of opportunity driven from ceasing engagement with misidentified HCPs.
GenAI can greatly improve accuracy and efficiency at multiple steps of the debarred HCP identification process.
Trinity Case Study
Improving Data Operations Efficiency through GenAI-Powered Process Automation
The Situation
A top 10 pharma company was looking to improve debarred HCP identification (ID) by enhancing processes to ensure efficiency and adherence to the highest standards of regulatory compliance.
The prior method resulted in the loss of opportunities to engage with HCPs who weren’t actually debarred because:
- It manually identified probable debarred HCP IDs, leading to flagging of all IDs with partial matches.
- There was difficulty in extracting data from the exclusion notices, which would have helped with exclusion criteria for HCP IDs. The manual, tedious process of getting information from exclusion notices often led to errors and the need for oversight.
Trinity’s Solution
Trinity AI recognized these issues as data operations efficiency challenges. An innovative approach using GenAI, sentence transformer models and a structured methodology for data extraction, cleaning, enrichment and matching can maintain strict compliance, optimize opportunities to engage with HCPs and minimize risk:
Project Outcomes
20% increase
in exact
matches
68% reduction
in potential
matches
Improved time
and resource
efficiencies
Reduced
non-compliance
risk
Won company-wide
GenAI innovation
award
Authors: Nabha Subramanya and Diraj Settipally
Download the case study
Trinity AI’s GenAI-powered process automation solution to improve data operations efficiency won QC Data Management Solution of the Year in the 2024 BioTech Breakthrough Awards.
Have a question? Reach out to our experts.
Ask Us A Question | Schedule A Meeting | info@trinitylifesciences.com
Explore Trinity AI | www.trinitylifesciences.com
Related Intelligence
Webinars
Generative AI in Pharma – Five Years From Now
Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments […]
Watch Now
Blog
Foundational Differentiation: CE Requires Efficient Operationalization of Data
What is data operationalization, and why is it important in life sciences? The ability to integrate insights from your data into your business workflows is commonly referred to as data operationalization. Throughout life sciences organizations, functional needs and behaviors have evolved, making data operationalization at scale a vital source of competitive advantage for life sciences. […]
Read More
Webinars
The Future of Patient Finding
Available On Demand
Patient finding is more than a buzzword. Ready to challenge the status quo? With more data, advancements in AIML and greater access to insights, it is not surprising that patient finding is evolving. Many pharma organizations have deep-rooted ideas about what patient finding requires, but they often miss the opportunity to put the patient at […]
Watch Now